January 9, 2025: La biotech lyonnaise MaaT Pharma prouve les vertus du microbiote - Les Echos (French Only) - MaaT Pharma

To see the article, click here!

Previous PostJanuary 9, 2025: MaaT's phase 3 GvHD trial hits goal, teeing up microbiome filing if cash crunch clears - Fierce Biotech
Next PostJanuary 9, 2025: ARES Trial of MaaT013 in GI-aGVHD Meets Primary End Point of GI-ORR - OncLive

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club